跳至主要内容
临床试验/NCT06298461
NCT06298461招募中4 期

Bowel Preparation for Colonoscopy Among Individuals With IBD: A Randomized Controlled Trial

University of Manitoba1 个研究点 分布在 1 个国家目标入组 418 人开始时间: 2024年7月4日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
招募中
入组人数
418
试验地点
1
主要终点
Quality of bowel cleanliness

研究概览

简要总结

The purpose of this study is to compare how effective and how tolerable two different bowel preparation laxatives are for colonoscopy. The aim is to compare oral sulfate solution (OSS) to another laxative called 2L polyethylene glycol (PEG) solution to see which is more effective and more tolerable by individuals with IBD (Crohn's disease or Ulcerative colitis).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Crohn's disease or ulcerative colitis patients scheduled or about to be scheduled for colonoscopy.
  • Age > 18 years
  • Out-patients

排除标准

  • Prior subtotal or total colorectal resection
  • Contraindications to use of 2L polyethylene glycol (2L-PEG) or Oral Sulfate Solution (OSS): Known renal insufficiency, congestive heart failure, cirrhosis, severe electrolyte imbalance.
  • Colonoscopy being repeated because of poor preparation in the preceding six months.
  • Allergies to the employed bowel preparations
  • Toxic megacolon, ileus, suspected or diagnosed bowel obstruction.
  • IBD patients thought to be too sick to undergo a full colonoscopy preparation in the opinion of the investigator/treating physician; hospitalized crohn's disease or ulcerative colitis patients.

研究组 & 干预措施

OSS

Active Comparator

干预措施: KleanLyte (Drug)

2L PEG

Active Comparator

干预措施: Bi-PegLyte (Drug)

结局指标

主要结局

Quality of bowel cleanliness

时间窗: 1 year

The primary outcome will be adequate quality of bowel cleanliness. Proportion with adequate cleansing will be measured by the Ottawa scale score as a binary adequate/inadequate score (≤7) will be recorded.

次要结局

  • Volume of laxative intake(1 year)
  • Endoscopic Outcomes(1 year)
  • Patient experience data(1 year)
  • Crohn's disease or ulcerative colitis flares after colonoscopy(One month)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验